Observational Study
Copyright ©The Author(s) 2023.
World J Cardiol. Apr 26, 2023; 15(4): 165-173
Published online Apr 26, 2023. doi: 10.4330/wjc.v15.i4.165
Table 2 Comparison between survivors and no survivors, n %
Variable
All patients
Survivors (No. 28)
No survivors (No. 33)
P value
Clinical data
Age (yr), mean ± SD54.3 ± 10.350.1 ± 11.658.0 ± 7.30.003
Gender, M/F45/16 (73.8/26.2)18/10 (40.0/62.5)6/27 (60.0/37.5)0.121
BMI (kg/m2), mean ± SD32.9 ± 5.331.8 ± 4.033.8 ± 6.10.138
Charlson index, median (IQR)2.0 (1.0-3.0)2.0 (1.0-3.0)2.0 (1.0-3.0)0.772
Time from symptoms’ onset to ICU (d), median (IQR)13 (10-13)10 (8-13)13 (10-15)0.066
SOFA, median (IQR)8.0 (7.0-10.0)7.5 (5.5-9.0)10.0 (8.0-10.0)0.01
Mechanical ventilation length to ECMO support (d), median (IQR)6.0 (8.0-11.0)6.5 (4.5-9.5)10.0 (7.0-12.0)0.006
ECMO duration (d), median (IQR)22 (13-42)35 (19-48)18 (10-30)0.015
ICU death33 (54.1)---
Biohumoral data
Creatinine (mg/dL), median (IQR)1.00 (0.70-1.88)0.82 (0.60-1.35)1.60 (0.77-2.00)0.03
D-dimer (ng/mL), median (IQR)3694 (2153-7326)3948 (1740-13095)3600 (2378-5007)0.418
CRP (mg/dL), median (IQR)140 (86-143)120 (85-172)164 (97-215)0.553
IL-6 (pg/mL), median (IQR)35.5 (7.9-71.0)46.5 (6.8-107.0)35.5 (20.5-59.0)0.851
Troponin (pg/mL), median (IQR)20.5 (15.0-39.0)34.0 (15.0-115.0)22.0 (9.0-50.0)0.281
NT-pro BNP (pg/mL), median (IQR)875 (355-1754)734 (254-1542)1272 (586-1870)0.064
LDH IU/L, median (IQR)466 (378-540)423 (367-513)475 (426-543)0.089
Echocardiographic data
LVEF (%)63.9 ± 7.665.6 ± 8.162.5 ± 6.90.113
RV/LV0.58 ± 0.170.58 ± 0.190.58 ± 0.160.945
TAPSE (mm)18.0 (10.0-21.0)19.0 (10.0 ± 22.5)18.0 (10.0-21.0)0.375
RVDD34 (55.7)13210.275
sPAP (mmHg)58.4 ± 9.460.2 ± 7.661.3 ± 10.70.638
E/e111 ± 310.7 ± 2.911.6 ± 3.70.34
TAPSE/sPAP (mm/mmHg)0.28 ± 0.130.29 ± 0.130.27 ± 0.130.692
Ventilatory parameters
PEEP (cm H2O)12.2 ± 2.312.3 ± 2.312.2 ± 2.40.91
PO2/FiO262 (50-88)66 (54-88)60 (50-88)0.442
Norepinephrine (μg/kg/min), mean ± SD0.34 ± 0.220.30 ± 0.200.35 ± 0.240.388